FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Stereotaxis, Inc. Stock AnalysisComprehensive stock analysis for Stereotaxis, Inc. (STXS) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSTXS
STXS
Stereotaxis, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
STXS
Home🔹Stocks🔹Stereotaxis, Inc.

Stereotaxis, Inc.

🇺🇸STXS•AMEX

Stereotaxis, Inc.

🇺🇸STXS•AMEX
Market cap
$129.27M
Sentiment

Your view on STXS

Mkt Cap
$129.27M
Sentiment
Your view
STXS
Stereotaxis, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
STXS
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Stereotaxis, Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
David Leo Fischel C.A.I.A.,
Headquarters
710 North Tucker Boulevard, Saint Louis, MO, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
David Leo Fischel C.A.I.A.,
Headquarters
710 North Tucker Boulevard, Saint Louis, MO, US
Description

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.

The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room.

In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters.

Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents.

The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Stereotaxis, Inc., and the rating behind it. STXS last traded at $1.32; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Stereotaxis, Inc.. Starting points for Stereotaxis, Inc.: EPS -$0.22, beta 1.42 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Stereotaxis, Inc.. Stereotaxis, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Stereotaxis, Inc.. Trailing twelve-month EPS for Stereotaxis, Inc. stands at -$0.22. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Stereotaxis, Inc.. Stereotaxis, Inc. has reported as a listed company since 2004. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Stereotaxis, Inc. valued side by side against its closest peers. Stereotaxis, Inc. is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Stereotaxis, Inc., and how their positions are changing. At a $129.3M market value, institutional positions materially move Stereotaxis, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Stereotaxis, Inc. executives and directors. Shares of Stereotaxis, Inc. have traded between $1.54 and $3.59 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Stereotaxis, Inc.. Stereotaxis, Inc. is a $129.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Stereotaxis, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Stereotaxis, Inc.. Coverage tracks Stereotaxis, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • ARCT — Arcturus Therapeutics Holdings Inc.
  • CVRX — CVRx, Inc.
  • HUMA — Humacyte, Inc.
  • MDXH — MDxHealth S.A.
  • NEO — NeoGenomics, Inc.
  • OSUR — OraSure Technologies, Inc.
  • QTRX — Quanterix Corporation
  • SGMT — Sagimet Biosciences Inc.

More Medical - Instruments & Supplies companies

  • SVSO — SheerVision, Inc.
  • TCGGY — Tecan Group AG
  • TCHBF — Tecan Group AG
  • TDVXF — Tobii Dynavox AB (publ)
  • TFX — Teleflex Incorporated
  • TGLVY — Top Glove Corporation Bhd.
  • TRJ.AX — Trajan Group Holdings Limited
  • TRUMF — Terumo Corporation
  • TRUMY — Terumo Corporation
  • TSNLF — Tristel PLC
  • TUTH — Standard Dental Labs Inc.
  • UTMD — Utah Medical Products, Inc.

ETFs holding Stereotaxis, Inc.

  • IWC — iShares Micro-Cap ETF (0.02%)
  • VTWG — Vanguard Russell 2000 Growth ETF (0.01%)
  • IWO — iShares Russell 2000 Growth ETF (0.01%)

News

Latest Market News